Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity

[wpbb post:title]
Katie Mckenna, PHD, Postdoctoral Fellow Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital Methodist Hospital
  • Targeting non-small cell lung cancer using a cell carrier system to deliver an oncolytic & immunostimulatory adenovirus

  • Efficacy of oncolytic virotherapy in 3D cell culture and in vivo

  • Assessing T cell functionality with single-cell proteomics

2021-05-06T09:56:28-04:00